Sangamo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.About SGMO
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases.
CEOAlexander D. Macrae
CEOAlexander D. Macrae
Employees183
Employees183
HeadquartersRichmond, California
HeadquartersRichmond, California
Founded1995
Founded1995
Employees183
Employees183
SGMO Key Statistics
Market cap147.75M
Market cap147.75M
Price-Earnings ratio-0.99
Price-Earnings ratio-0.99
Dividend yield—
Dividend yield—
Average volume4.24M
Average volume4.24M
High today$0.454
High today$0.454
Low today$0.435
Low today$0.435
Open price$0.445
Open price$0.445
Volume3.11M
Volume3.11M
52 Week high$2.82
52 Week high$2.82
52 Week low$0.3846
52 Week low$0.3846
Stock Snapshot
As of today, Sangamo Therapeutics(SGMO) shares are valued at $0.44. The company's market cap stands at 147.75M, with a P/E ratio of -0.99.
On 2025-12-18, Sangamo Therapeutics(SGMO) stock traded between a low of $0.44 and a high of $0.45. Shares are currently priced at $0.44, which is +0.2% above the low and -4.0% below the high.
The Sangamo Therapeutics(SGMO)'s current trading volume is 3.11M, compared to an average daily volume of 4.24M.
In the last year, Sangamo Therapeutics(SGMO) shares hit a 52-week high of $2.82 and a 52-week low of $0.38.
In the last year, Sangamo Therapeutics(SGMO) shares hit a 52-week high of $2.82 and a 52-week low of $0.38.
People also own
Based on the portfolios of people who own SGMO. This list is generated using Robinhood data, and it’s not a recommendation.